Growth Metrics

Jazz Pharmaceuticals (JAZZ) Gross Profit (2016 - 2025)

Jazz Pharmaceuticals has reported Gross Profit over the past 16 years, most recently at $1.0 billion for Q4 2025.

  • Quarterly Gross Profit rose 8.85% to $1.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.9 billion through Dec 2025, up 8.48% year-over-year, with the annual reading at $3.8 billion for FY2025, 3.89% up from the prior year.
  • Gross Profit was $1.0 billion for Q4 2025 at Jazz Pharmaceuticals, up from $997.2 million in the prior quarter.
  • Over five years, Gross Profit peaked at $1.0 billion in Q4 2025 and troughed at $567.4 million in Q1 2021.
  • The 5-year median for Gross Profit is $808.7 million (2022), against an average of $829.8 million.
  • Biggest five-year swings in Gross Profit: rose 27.83% in 2022 and later rose 1.7% in 2025.
  • Tracing JAZZ's Gross Profit over 5 years: stood at $760.6 million in 2021, then increased by 5.81% to $804.8 million in 2022, then grew by 12.42% to $904.7 million in 2023, then increased by 6.05% to $959.5 million in 2024, then rose by 8.85% to $1.0 billion in 2025.
  • According to Business Quant data, Gross Profit over the past three periods came in at $1.0 billion, $997.2 million, and $929.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.